SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000875045-16-000056
Filing Date
2016-05-03
Accepted
2016-05-03 07:31:52
Documents
13
Period of Report
2016-05-03
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8-kmay32016.htm 8-K 21204
2 EXHIBIT 99.1 a8-kmay32016pressrelease.htm EX-99.1 23815
3 EXHIBIT 99.2 investorslides05021910.htm EX-99.2 11264
4 biogenlogostandard.jpg GRAPHIC 756402
5 investorslides05021910001.jpg GRAPHIC 76433
6 investorslides05021910002.jpg GRAPHIC 348883
7 investorslides05021910003.jpg GRAPHIC 233132
8 investorslides05021910004.jpg GRAPHIC 166507
9 investorslides05021910005.jpg GRAPHIC 216440
10 investorslides05021910006.jpg GRAPHIC 146229
11 investorslides05021910007.jpg GRAPHIC 162291
12 investorslides05021910008.jpg GRAPHIC 178184
13 investorslides05021910009.jpg GRAPHIC 228244
  Complete submission text file 0000875045-16-000056.txt   3499077
Mailing Address 225 BINNEY STREET CAMBRIDGE MA 02142
Business Address 225 BINNEY STREET CAMBRIDGE MA 02142 7814642000
BIOGEN INC. (Filer) CIK: 0000875045 (see all company filings)

IRS No.: 330112644 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19311 | Film No.: 161613613
SIC: 2836 Biological Products, (No Diagnostic Substances)